Next Generation Sequencing Testing (NGS)
- NHS Blood and Transplant
Procurement identifier (OCID): ocds-h6vhtk-0514f8
Description
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Notices
UK4: Tender notice
- Notice identifier
- 2026/S 000-006523
- Published
- 26 January 2026, 11:05am
26 January 2026, 11:05am (latest version)
- 12 January 2026, 8:35am
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-021932
- Published
- 15 May 2025, 4:45pm